There are moments when the body’s rhythms whisper clues long before the louder alarms of disease demand our attention. A cough that lingers after dusk, a breath that comes slower after a day in the sun these are the gentle ripples of lived experience, yet they may carry deeper meanings. In the quiet cross-currents between mind and body, scientists are beginning to discern patterns that ask us to rethink old categories. One such pattern involves the interplay between asthma and depression, a connection that now appears to be rooted in pathways more biologically distinct than once assumed.
At first glance, asthma and depression may seem like distant relatives in the vast family of human health one anchored in breath and lungs, the other in mood and mind. Yet new research suggests that when people living with asthma also experience symptoms of depression, the biological signature of that distress may differ from the familiar patterns seen in primary major depressive disorder. In a study led by researchers at Hiroshima University and collaborators, adults with asthma who reported depressive symptoms had higher levels of brain-derived neurotrophic factor (BDNF) in their blood a protein that typically shows lower levels in major depressive disorder.
BDNF is a protein with a multifaceted role in the body. It supports nerve growth and survival, and helps shape how neurons connect and communicate. In the brain, reduced BDNF has long been associated with the biological landscape of major depression. Yet BDNF is also produced in the lungs, where it rises in response to airway inflammation a hallmark of asthma’s underlying biology. This dual role raises intriguing questions: could the depressive symptoms seen in people with asthma be partly a reflection of inflammatory stress carried in the breath as much as in the mind?
In the Hiroshima University study, about 140 adults with asthma were evaluated for depressive and anxiety symptoms, and their blood levels of BDNF were measured alongside markers of physical activity. Rather than following the expected pattern seen in primary depression where BDNF levels fall — the participants with asthma and depressive symptoms showed elevated BDNF levels. Moreover, these higher levels appeared linked with more severe asthma symptoms.
There is a poetic subtlety to this finding. The very protein that in one context signals resilience and growth in the brain may in another context be a messenger of inflammation or physiological stress. In the lungs, elevated BDNF may influence nerve sensitivity and inflammation, potentially amplifying the experience of both breathlessness and mood disturbance. The researchers also found that people who were less active tended to report worse mood symptoms, a reminder of how physical limitation and emotional experience can intertwine.
These insights do not simplify the lived experience of depression in people with asthma; rather, they add depth to it. They suggest that depressive symptoms in this group may arise from biological signals tied to chronic inflammation and respiratory stress, in addition to and perhaps separate from traditional pathways associated with major depressive disorder. In practical terms, this means that health care providers may need to consider asthma and mood symptoms together, recognizing that addressing inflammation and physical health could also support emotional wellbeing.
As science continues to map the complex terrain between somatic disease and emotional experience, these findings offer a gentle but important reminder: the body’s systems do not operate in isolation. Understanding how one condition may shape another not merely through experience, but through distinct biological rhythms enriches how we perceive, diagnose, and care for the whole person.
AI Image Disclaimer “Illustrations were produced with AI and serve as conceptual depictions.”
Sources:
EurekAlert! Asia Research News Mirage News The Journal of Allergy and Clinical Immunology: In Practice Hiroshima University research reporting.
Published by Banx Network. This article is part of the Banx decentralized media programme, powered by the BXE token on the XRP Ledger.




